BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11703423)

  • 1. Effects of granulocyte-colony stimulating factor in the treatment of diabetic foot infection.
    Yönem A; Cakir B; Güler S; Azal O O; Corakçi A
    Diabetes Obes Metab; 2001 Oct; 3(5):332-7. PubMed ID: 11703423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection.
    Gough A; Clapperton M; Rolando N; Foster AV; Philpott-Howard J; Edmonds ME
    Lancet; 1997 Sep; 350(9081):855-9. PubMed ID: 9310604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.
    Cruciani M; Lipsky BA; Mengoli C; de Lalla F
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006810. PubMed ID: 19588405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case report on therapy with granulocyte stimulating factor in diabetic foot].
    Kreyden OP; Hafner J; Burg G; Nestle FO
    Hautarzt; 2001 Apr; 52(4):327-30. PubMed ID: 11382124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.
    Cruciani M; Lipsky BA; Mengoli C; de Lalla F
    Cochrane Database Syst Rev; 2013 Aug; (8):CD006810. PubMed ID: 23955465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers.
    Kästenbauer T; Hörnlein B; Sokol G; Irsigler K
    Diabetologia; 2003 Jan; 46(1):27-30. PubMed ID: 12637979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rhG-CSF on neutrophil functions and survival in sepsis induced diabetic rats.
    Cantürk Z; Cantürk NZ; Onen F
    Endocr Res; 1998 May; 24(2):141-57. PubMed ID: 9738693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced neutrophil functions by recombinant human granulocyte colony-stimulating factor in diabetic patients with foot infections in vitro.
    Peck KR; Son DW; Song JH; Kim S; Oh MD; Choe KW
    J Korean Med Sci; 2001 Feb; 16(1):39-44. PubMed ID: 11289399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rhG-CSF on neutrophil functions and bone marrow parameters in diabetic rats.
    Cantürk Z; Cantürk NZ; Cetinarslan B; Erçin C; Dökmetaş S; Sencan M
    Endocr Res; 1999; 25(3-4):381-95. PubMed ID: 10596730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized prospective controlled trial of recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection.
    de Lalla F; Pellizzer G; Strazzabosco M; Martini Z; Du Jardin G; Lora L; Fabris P; Benedetti P; Erle G
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1094-8. PubMed ID: 11257020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.
    Wiltschke C; Krainer M; Nanut M; Wagner A; Linkesch W; Zielinski CC
    J Interferon Cytokine Res; 1995 Mar; 15(3):249-53. PubMed ID: 7584671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A meta-analysis.
    Cruciani M; Lipsky BA; Mengoli C; de Lalla F
    Diabetes Care; 2005 Feb; 28(2):454-60. PubMed ID: 15677817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of recombinant human granulocyte colony-stimulating factor on neutrophil morphology, function and phenotype in patients with acute leukemia undergoing chemotherapy].
    Huang HH; Zhong JH; Han XF; Xuan ZH; Han JY; Chen FY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1033-7. PubMed ID: 16403274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive granulocyte colony-stimulating factor therapy for diabetic foot infections.
    Reed KS; Pai MP
    Ann Pharmacother; 2004 Dec; 38(12):2150-3. PubMed ID: 15494384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
    Huang P; Li S; Han M; Xiao Z; Yang R; Han ZC
    Diabetes Care; 2005 Sep; 28(9):2155-60. PubMed ID: 16123483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.
    Drossou-Agakidou V; Kanakoudi-Tsakalidou F; Sarafidis K; Taparkou A; Tzimouli V; Tsandali H; Kremenopoulos G
    Eur J Pediatr; 1998 Jul; 157(7):583-8. PubMed ID: 9686822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.
    Hustinx WN; Van Kessel CP; Heezius E; Burgers S; Lammers JW; Hoepelman IM
    Clin Exp Immunol; 1998 May; 112(2):334-40. PubMed ID: 9649199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.